Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The DRIaDD group works on drug-resistant bacterial infections and other communicable disease including influenza, hepatitis E, and SARS-CoV-2.

Numerous multicoloured pills

Major research themes include:

  • Quantifying the burden of disease due to these pathogens
  • Developing and evaluating interventions to reduce this disease burden
  • Improving our basic understanding of their epidemiology and population biology
  • Developing new methods to support the above.

Members of the group use a diverse array of methodologies including novel statistical approaches, mechanistic mathematical models, qualitative research methods, analyses of whole genome sequencing and meta-genomic data, health economics, meta-analyses and prospective intervention studies including randomised trials.

Visit the DRIaDD pages on the NDM-CGHR website

DRIaDD Researchers